The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Identfication and Treatment of New Inflammatory Triggers for Complex Regional Pain Syndrome: Small Intestinal Bacterial Overgrowth and Obstructive Sleep Apnea
A A Case Rep
May 2016
https://mail.google.com/mail/u/0?ui=2&ik=b5d7923c33&attid=0.3&permmsgid=msg-f:1668161843235939361&th=1726805badf06421&view=att&disp=safe
Laurie Marzell, ND - LDN Case Studies (2017 Conference) (LDN, low dose naltrexone)
Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.